11/13/2025
🚀In Case You Missed It: HEALWELL AI Q3 2025 Earnings Call Highlights 🚀
James Lee, CEO of HEALWELL AI commented “In Q3, we announced and have now completed the simplification of HEALWELL — a major milestone that marks our transition from a conglomerate into a focused, pure-play software and AI company. Our diverse geographic and product mix has allowed us to maintain positive Adjusted EBITDA through the traditionally slower summer quarter. These achievements position us strongly for the future, with the focus and resources needed to scale as a leading healthcare AI company.”
Key highlights:
· During Q3-2025, HEALWELL reported positive Adjusted EBITDA of $0.7 million, compared to an Adjusted EBITDA loss of $2.8 million in Q3-2024. This marks the Company’s second consecutive quarter of positive Adjusted EBITDA, highlighting continued ex*****on improvements and stronger financial performance. During Q3-2025, the Company’s IFRS net loss from continuing operations was $16.0 million compared to a net loss of $8.7 million for the previous year.
· During Q3-2025, HEALWELL acquired the remaining 49% interest in Pentavere Research Group Inc., gaining full ownership of the AI company and strengthening its AI segment with Pentavere’s DARWEN™ platform for early disease detection.
· Subsequent to the end of the quarter, HEALWELL completed a series of strategic divestments, including the sale of its Polyclinic Family Medicine and Specialty Clinics, the sale of its majority interest in Mutuo Health Solutions, and the formation of a 50/50 clinical research joint venture with WELL Health Technologies Corp.
Click here to watch:
HEALWELL AI’s leadership team present the company’s Fiscal Third Quarter 2025 financial results and discuss recent business highlights, strategic development...